News-Medical speaks to Dr. Dan Lavery about the LouLou Foundation, a non-profit organization dedicated to CDLK5 Deficiency Disorder.
Trial drug offers hope to block early infection of novel coronavirus
New family of molecules to join altered receptors in Alzheimer's, Parkinson's and Huntington's
Antibody recovered from SARS survivor reveals potential vulnerability of new coronavirus
Virological findings from Germany's first group of COVID-19 patients
Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare
South Australian researchers make rapid progress in developing a COVID-19 vaccine
Protein Supplements and Neurodegenerative Disorders
Does the Hand You Write with Affect Brain Development?
What is Acute Respiratory Distress Syndrome (ARDS)?
Dr. Andrew Webb
Dr. Andrew Webb describes how his lab uses mass spectrometry-based techniques to understand the role of post-translational modifications in human disease.
Dr Maureen Bunger
Lonza is a large, multinational corporation serving the entire pharmaceutical product development and manufacturing pipeline, from non-clinical research products to final dosage and delivery solutions.
Dr. Dan Lavery